Growth Metrics

DBV Technologies (DBVT) Long-Term Investments (2015 - 2019)

DBV Technologies (DBVT) reported Long-Term Investments of $18.3 million for Q4 2019, up 165.03% year-over-year from $6.9 million in Q4 2018, and up 165.03% on a QoQ basis from $6.9 million in Q4 2018.

DBV Technologies (DBVT) has 5 years of Long-Term Investments data on file, last reported at $18.3 million in Q4 2019.

  • Quarterly Long-Term Investments rose 165.03% year-over-year to $18.3 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $18.3 million (up 165.03% YoY) and the FY2019 annual result came in at $18.3 million, up 165.03% from the prior year.
  • Long-Term Investments improved to $18.3 million in Q4 2019 per DBVT's latest filing, from $6.9 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $18.3 million in Q4 2019 and bottomed at $3.0 million in Q4 2016.
  • The 5-year median for Long-Term Investments is $3.5 million (2017), against an average of $6.9 million.
  • The widest annual swing landed in 2016, when Long-Term Investments decreased 0.26%; it then soared 165.03% in 2019.
  • Tracing DBVT's Long-Term Investments over 5 years: stood at $3.0 million in 2015, then slipped by 0.26% to $3.0 million in 2016, then advanced by 19.66% to $3.5 million in 2017, then soared by 94.17% to $6.9 million in 2018, then soared by 165.03% to $18.3 million in 2019.
  • Per Business Quant, the three latest DBVT Long-Term Investments figures stand at $18.3 million (Q4 2019), $6.9 million (Q4 2018), and $3.5 million (Q4 2017).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 505,194.89
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.75 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 9.79 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 22.17 Mn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2019 18.25 Mn
Dec 31, 2018 6.89 Mn
Dec 31, 2017 3.55 Mn
Dec 31, 2016 2.96 Mn
Dec 31, 2015 2.97 Mn